Product Roadmap

The product roadmap goes through five distinct phases, each building upon the previous to achieve amassing high quality population scale health data and building a decentralized health data marketplace which will eventually enable building decentralized health apps with.

Phase 1: Establishes a strong foundation by piloting an oncology EHR system and accelerating their researchers research. This enables Jori to have a product that has PMF with an oncology research center, where we can then strengthen the product with more data.

Phase 2: focuses on scaling to multiple NCI-designated centers, diversifying into general-purpose healthcare EHR solutions, for oncology care centers (not research hospitals) and launching an early web2 data marketplace. (Jori has one of the best cancer datasets at this point)

Phase 3: Jori releases the Patient app and we release a standard EHR for all hospitals into broader healthcare applications and patient-centric decentralization with the Jori Patient App.

Phase 4: Jori patient app enables patients to bridge their data to their wallet and they fully control their health information. Jori looks at integrating with a de-pin device so that onchain visits can be tracked and permissions can be built to enable sharing your data at the visit.

Phase 5: Introduces a decentralized insurance model, this is a model that leverages the totality of patient data in jori and is able to make instant decisions to accept and deny claims. This enables providers to have instant settlements. Jori insurance DAO is largely funded by revenue and profit of the patient data.

Phase 1: 0 to 12 Months – Establishing Foundations

Revenue Goal: $500,000

The initial phase targets a focused entry point within oncology, laying the groundwork for broader adoption. The non-commercial pilot at Rutgers Cancer Hospital is central to this phase, enabling Jori Health to deeply understand the unique needs of oncology researchers. The pilot focuses on developing a specialized tool to aid researchers in drafting papers, conducting advanced data analytics, and accelerating their discoveries.

Simultaneously, Jori Health builds the first iteration of its electronic health record (EHR) system, tailored to oncology. This foundational EHR ensures seamless integration with existing systems while maintaining HIPAA compliance. Integrated into this EHR will be the Jori Ai agent which is able to assistant in queries about the patient data as well as write code The goal is to demonstrate the system’s practicality, security, and utility in a high-value healthcare vertical.

Additionally, the groundwork for a data marketplace is laid by initiating partnerships with hospitals and pharmaceutical companies. This phase explores the value proposition of de-identified patient data, positioning Jori Health to monetize healthcare data in subsequent phases.

Phase 2: 12 to 24 Months – Scaling and Diversifying

Revenue Goal: $2.5 Million

Building on Phase 1, Jori Health scales its oncology EHR system to four additional NCI-designated centers, targeting $2.5 million in annual revenue. This expansion validates the system’s scalability, strengthens its reputation, and creates a solid base of early adopters.

The development focus shifts to creating a general-purpose EHR system that supports multiple healthcare verticals. This evolution ensures that Jori Health’s solution is adaptable to various specialties while maintaining interoperability and compliance with standardized data export mandates. The system is optimized for seamless data migration, reducing barriers for new adopters.

Phase 2 also sees the launch of Jori’s data marketplace. This marketplace enables hospitals to sell de-identified patient data to pharmaceutical companies and researchers, creating a new revenue stream while prioritizing patient privacy. The marketplace’s success depends on robust privacy protocols and clear incentives for both data providers and buyers.

Phase 3: 24+ Months – Broader Healthcare Adoption and Patient Decentralization

Revenue Goal: $20 Million

In Phase 3, Jori Health extends its reach beyond oncology, rolling out its EHR system to non-oncology health facilities. By leveraging its cost-effectiveness and efficiency, the system becomes an attractive alternative for healthcare providers across specialties. This broader adoption is supported by continuous improvements in usability and scalability.

The introduction of the Jori Patient App marks a transformative shift in this phase. Patients, starting with oncology cases, gain full ownership and control of their health data. The app offers a seamless user experience for accessing, managing, and sharing data. To drive adoption, Jori Health provides substantial sign-up bonuses, funded by the exponential value created through its data marketplace and other revenue streams. This step not only empowers patients but also strengthens the ecosystem by ensuring high-quality, patient-verified data.

Phase 4: 4 Years – Decentralized Insurance and Ecosystem Integration

Revenue Goal: Expansion beyond healthcare data monetization

The final phase introduces Jori Health’s decentralized insurance protocol, reimagining healthcare insurance through blockchain technology. This model focuses on automatic fraud detection, instant payouts, and competitive pricing. By leveraging real-time doctor-patient interactions and patient-owned data, the insurance system aligns incentives for better healthcare outcomes.

The decentralized insurance model reduces overhead costs traditionally associated with insurance by eliminating inefficiencies and fraud. Patients benefit from lower premiums, while providers experience faster claim resolutions and more accurate reimbursements. This phase cements Jori Health’s position as a comprehensive, blockchain-enabled healthcare ecosystem, capable of scaling its solutions globally.